Search app
CSR Racing 2


Last Update
View in store

Store Performance Index


Store Performance Index shows overall performance of your app on app stores. It is based on combined ASO & reviews metrics.

See more data

Ratings & Reviews performance for Evicardio

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,


Avg rating,



2436 chars

Evicardio was designed to provide the clinician and investigator with a database of more than 800 randomized clinical trials in cardiology, than may collaborate in the evidence base clinical practice. The application includes four main tools Clinical trials database New data calculator My trials (a personal database with new data) Evidence based cardiology manual (only in Spanish) 1) Clinical trials database The information may be consulted traditionally as abstracts, and more powerfully with two statistical "calculators": a)Clinical trials events: Evaluates drug/intervention trials with the parameters of evidence based medicine (EBM): statistical significance, absolute risk reduction (ARR), risk reduction (RR), relative risk reduction (RRR), number necessary to treat NNT, and odds ratio (OR); b) Metaanalysis: to evaluate with the method of Mantel Hanszel Peto the main effect of series of clinical trials. Trials may be selected using 4 criteria of search (acronym, drug/intervention, therapeutic group, disease) and each event can be analyzed individually or in an overview grouping essays with similar designs. The analysis can be saved in your personal archive. 2) New data calculator Evicardio allows you to enter new trials in your personal database, using this two calculators (events in a single trial, metaanalysis of many trials and a third for Diagnostic tests: to evaluate diagnostic methods (sensitivity, specificity, positive and negative predictive value, likelihood ratio, post test) and also gives you the chance to change the prevalence in order to estimate the probability in different risk populations. All the data can be saved and accede afterwards in your personal database. 3) My trials You can keep in your file new information read from the papers, or add to previous metaanalysis new data. Evicardio was developed by GEDIC. The original project leaders were Hernán Doval, Carlos Tajer y Juan Gagliardi. As coordinators of the work Susana Lipshitz, Javier Mariani and Maximiliano de Abreu. Cardiologists that help with the summaries: Adriana Acosta, Laura Antonietti, Aníbal Arias, Laura Arias, Rafael Feldman, Diego Funes, Javier Guetta, Luciano Lucas, Diego Manente, Walter Mason y Mariano Trevisan. The computing-design and application was developed in collaboration with Pixeloide, Inc. As secretary we thank the huge help of Silvina Ruth Bravo. EVICARDIO ® has copyright.

 Why to reply to reviews?

User reviews affect conversion to installs and app rating. Featured and helpful reviews are the first to be noticed by users and in case of no response can affect download rate. This is why it is highly recommended to reply to them.

CSR Racing 2

About Evicardio

Developed by Pixeloide.

Evicardio is ranking in   Medical

Last update was at Noneand the current version is 1.6.

To see all other keys and revenue click here 725186752

Evicardio have a 0a user reviews.

Evicardio was released in the App Store. It is developed by Pixeloide, who have also released the following apps.

Evicardio has 0 user reviews.​

Evicardio has an average rating of 0.0. ​The latest version of Evicardio 1.6​ ​​was ​released on None​.

You can download Evicardio ​here

Find growth insights on our blog

How to Respond to Google Play Reviews

How to Respond to Google Play Reviews

How to Respond to App Store Reviews

How to Respond to App Store Reviews

AppFollow identifies top apps in the App Store and Google Play in 2020

AppFollow identifies top apps in the App Store and Google Play in 2020

React to user feedback and market trends faster